Product
Standard age based SPAQ administration
1 clinical trial
1 indication
Indication
MalariaClinical trial
A Study Protocol to Assess the Chemoprevention Efficacy of Sulphadoxine-Pyrimethamine Plus Amodiaquine (SPAQ) and Resistance Marker Prevalence in Children 3-59 Months in Sokoto and Kwara States, Nigeria.Status: Recruiting, Estimated PCD: 2023-09-15